4
Changes in Ownership
Alkermes plc. Filed Acc 0001520262-26-000103
EVP R&D, Chief Medical Officer sold 9,000 shares at an average $51.51 ($463,621)
- EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $19.34 | $96,700 | 82,389 | D |
| 2026-07-01 | Sale : show line 2 in the form 10b5-1 | −8,300 | $51.46 | $427,129 | 74,089 | D |
| 2026-07-01 | Sale : show line 3 in the form 10b5-1 | −700 | $52.13 | $36,492 | 73,389 | D |
| Open-market sales · 9,000 sh · avg $51.51 · $463,621 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Buy) | −5,000 | 1,356 | D |
Loading xslF345X06/form4.xml…